UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 523

Sortiert nach

Deferasirox improves hematopoiesis after allogeneic hematopoietic SCT

Bone marrow transplantation (Basingstoke), 2014-04, Vol.49 (4), p.585-587

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines

Leukemia research, 2010-12, Vol.34 (12), p.1576-1588

2010

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)

Haematologica (Roma), 2008-10, Vol.93 (10), p.1514-1522

2008

Link zum Volltext

Verfügbarkeit prüfen

Primary plasma cell leukemia: a retrospective multicenter study of 73 patients

Annals of oncology, 2011-07, Vol.22 (7), p.1628-1635

2011

Link zum Volltext

Verfügbarkeit prüfen

Low-dose lenalidomide plus cytarabine induce complete remission that can be predicted by genetic profiling in elderly acute myeloid leukemia patients

Leukemia, 2014-04, Vol.28 (4), p.967-970

2014

Link zum Volltext

Verfügbarkeit prüfen

Environmental nanoparticles are significantly over-expressed in acute myeloid leukemia

Leukemia research, 2016-11, Vol.50, p.50-56

2016

Link zum Volltext

Verfügbarkeit prüfen

MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine

The pharmacogenomics journal, 2018-05, Vol.18 (3), p.444-449

2018

Link zum Volltext

Verfügbarkeit prüfen

THE BRAF INHIBITOR VEMURAFENIB PLUS RITUXIMAB PRODUCES A HIGH RATE OF DEEP AND DURABLE RESPONSES IN RELAPSED/REFRACTORY HAIRY CELL LEUKEMIA: UPDATED RESULTS OF A PHASE‐2 TRIAL

Hematological oncology, 2019-06, Vol.37 (S2), p.110-111

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of dasatinib in conjunction with α-interferon for the treatment of imatinib-resistant and dasatinib-resistant Ph+ acute lymphoblastic leukemia

Leukemia, 2009-09, Vol.23 (9), p.1687-1688

2009

Link zum Volltext

Verfügbarkeit prüfen

98 CLINICAL RESPONSE TO THE ASSOCIATION OF AZACITIDINE AND LENALIDOMIDE IN HIGH-RISK MYELODYSPLASTIC SYNDROMES. A RANDOMIZED PHASE II MULTICENTER STUDY

Leukemia research, 2015-04, Vol.39, p.S50-S50

2015

Link zum Volltext

Verfügbarkeit prüfen

251 TS, MTHFR AND XRCC1 GENETIC VARIANTS INFLUENCE THE OUTCOME OF MDS PATIENTS IRRESPECTIVELY OF IPSS RISK

Leukemia research, 2015-04, Vol.39, p.S125-S125

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study

Leukemia, 2002-09, Vol.16 (9), p.1609-1614

2002

Link zum Volltext

Verfügbarkeit prüfen

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

The Lancet (British edition), 2010-12, Vol.376 (9758), p.2075-2085

2010

Link zum Volltext

Verfügbarkeit prüfen

The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia - analysis of 848 patients

Leukemia, 2001-06, Vol.15 (6), p.903-909

2001

Link zum Volltext

Verfügbarkeit prüfen

Karyotype in acute myeloblastic leukemia : Prognostic significance for bone marrow transplantation in first remission : A european group for blood and marrow transplantation study

Blood, 1997-10, Vol.90 (8), p.2931-2938

1997

Link zum Volltext

Verfügbarkeit prüfen

High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate

Leukemia, 1997-12, Vol.11 (12), p.2075-2078

1997

Link zum Volltext

Verfügbarkeit prüfen

Long-term molecular complete remission with IFN-α in Ph+ adult acute lymphoid leukemia patients

Leukemia, 2008-08, Vol.22 (8), p.1617-1618

2008

Link zum Volltext

Verfügbarkeit prüfen

P.1.149: NBI IN THE DIAGNOSIS OF GASTROINTESTINAL GRAFT-VERSUS-HOST DISEASE: A FEASIBLE TOOL FOR DETECTING MUCOSA AND VASCULAR ABNORMALITIES AT THE TIME OF ENDOSCOPY

Digestive and liver disease, 2011, Vol.43, p.S197-S197

2011

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib

Leukemia, 2015-09, Vol.29 (9), p.1823-1831

2015

Link zum Volltext

Verfügbarkeit prüfen

Update on the role of autologous hematopoietic stem cell transplantation in multiple myeloma

Mediterranean journal of hematology and infectious diseases, 2012-01, Vol.4 (1), p.e2012069-e2012069

2012

Link zum Volltext

Verfügbarkeit prüfen

208 Iron chelation therapy with deferasirox in transfusion dependent myelodysplastic syndrome patients. Preliminary report from the prospective MDS0306 GIMEMA trial

Leukemia research, 2011, Vol.35, p.S81-S82

2011

Link zum Volltext

Verfügbarkeit prüfen

Myeloid Sarcoma: The Clinician's Point of View

Leukemia Research and Treatment, 2011-01, Vol.2011, p.410291-2

2011

Link zum Volltext

Verfügbarkeit prüfen

Myeloid sarcoma of liver: an unusual cause of jaundice. Report of three cases and review of literature

Histopathology, 2007-05, Vol.50 (6), p.802-805

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 523

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(472)
Mit Volltextzugriff
(398)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(294)
Humans
(284)
Life Sciences & Biomedicine
(252)
Hematology
(184)
Male
(175)
Female
(173)
Adult
(170)
Middle Aged
(161)
Biological And Medical Sciences
(152)
Medical Sciences
(140)
Aged
(100)
Oncology
(85)
Adolescent
(81)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(53)
Hematologic And Hematopoietic Diseases
(51)
Pharmacology. Drug Treatments
(49)
Remission Induction
(47)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(45)
Antineoplastic Agents
(42)
Treatment Outcome
(38)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Deferasirox improves hematopoiesis after allogeneic hematopoietic SCT

Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines

Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)

Primary plasma cell leukemia: a retrospective multicenter study of 73 patients

Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients

Low-dose lenalidomide plus cytarabine induce complete remission that can be predicted by genetic profiling in elderly acute myeloid leukemia patients

Environmental nanoparticles are significantly over-expressed in acute myeloid leukemia

MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine

THE BRAF INHIBITOR VEMURAFENIB PLUS RITUXIMAB PRODUCES A HIGH RATE OF DEEP AND DURABLE RESPONSES IN RELAPSED/REFRACTORY HAIRY CELL LEUKEMIA: UPDATED RESULTS OF A PHASE‐2 TRIAL

Efficacy of dasatinib in conjunction with α-interferon for the treatment of imatinib-resistant and dasatinib-resistant Ph+ acute lymphoblastic leukemia

98 CLINICAL RESPONSE TO THE ASSOCIATION OF AZACITIDINE AND LENALIDOMIDE IN HIGH-RISK MYELODYSPLASTIC SYNDROMES. A RANDOMIZED PHASE II MULTICENTER STUDY

251 TS, MTHFR AND XRCC1 GENETIC VARIANTS INFLUENCE THE OUTCOME OF MDS PATIENTS IRRESPECTIVELY OF IPSS RISK

Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia - analysis of 848 patients

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma

Karyotype in acute myeloblastic leukemia : Prognostic significance for bone marrow transplantation in first remission : A european group for blood and marrow transplantation study

High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate

Long-term molecular complete remission with IFN-α in Ph+ adult acute lymphoid leukemia patients

P.1.149: NBI IN THE DIAGNOSIS OF GASTROINTESTINAL GRAFT-VERSUS-HOST DISEASE: A FEASIBLE TOOL FOR DETECTING MUCOSA AND VASCULAR ABNORMALITIES AT THE TIME OF ENDOSCOPY

Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib

Update on the role of autologous hematopoietic stem cell transplantation in multiple myeloma

208 Iron chelation therapy with deferasirox in transfusion dependent myelodysplastic syndrome patients. Preliminary report from the prospective MDS0306 GIMEMA trial

Myeloid Sarcoma: The Clinician's Point of View

Myeloid sarcoma of liver: an unusual cause of jaundice. Report of three cases and review of literature

Suchergebnisse filtern